Home
About
Overview
Sharing Data
ORCID
Help
History (16)
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.
Principal Investigator
Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis.
NF-?B, Mesenchymal Differentiation and Glioblastoma.
Neuraxial Anesthesia and the Ubiquitous Platelet Count Question-How Low Is Too Low?
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neuraxial Anesthesia and the Ubiquitous Platelet Count Question-How Low Is Too Low?
Neuraxial Anesthesia and the Ubiquitous Platelet Count Question-How Low Is Too Low? Anesth Analg. 2021 06 01; 132(6):1527-1530.
View in:
PubMed
subject areas
Anesthesia, Epidural
Anesthesia, Obstetrical
Platelet Count
authors with profiles
Barbara M. Scavone